APA (7th ed.) Citation

N, M., M, H., C, A., B, W., A, B., S, R., . . . P, M. (2025). Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia. Science translational medicine, 17(794), eadr1476. https://doi.org/10.1126/scitranslmed.adr1476

Chicago Style (17th ed.) Citation

N, Maciocia, et al. "Preclinical Development of Anti-CD21 Chimeric Antigen Receptor T Cells to Treat T Cell Acute Lymphoblastic Leukemia." Science Translational Medicine 17, no. 794 (2025): eadr1476. https://doi.org/10.1126/scitranslmed.adr1476.

MLA (9th ed.) Citation

N, Maciocia, et al. "Preclinical Development of Anti-CD21 Chimeric Antigen Receptor T Cells to Treat T Cell Acute Lymphoblastic Leukemia." Science Translational Medicine, vol. 17, no. 794, 2025, p. eadr1476, https://doi.org/10.1126/scitranslmed.adr1476.